Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Autobahn Therapeutics to Participate in the Leerink Partners Biopharma Private Company Connect

Autobahn Therapeutics, a biotechnology company leveraging its brain-targeting chemistry platform, validated biology and biomarker-driven strategies to develop restorative treatments for people affected by central nervous system (CNS) disorders, today announced that Kevin Finney, President and Chief Executive Officer, will participate in the Leerink Partners Biopharma Private Company Connect on Wednesday, June 26, 2024.

About Autobahn Therapeutics

Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and neuroimmunologic clinical candidates leveraging its brain-targeting chemistry platform. Autobahn aims to unlock new therapeutic opportunities through precision tuning of CNS exposure, pursuing validated clinical and biologic targets, and guiding development with biomarkers. The company's pipeline is led by ABX-002, a thyroid hormone receptor beta (TR?) agonist being developed as a potential adjunctive treatment for people with major depressive disorder and bipolar disorder depression. Autobahn Therapeutics is based in San Diego. For more information, visit www.autobahntx.com.

These press releases may also interest you

at 16:34
NextStep Arthropedix, a growing orthopedic implants and procedures company, today announced the launch of TheRaytm Collared and Collarless Hip System....

at 16:15
For the third consecutive year, Concorde Career College?Portland's respiratory therapy program has been recognized for outstanding student outcomes by the Commission on Accreditation for Respiratory Care (CoARC). The "Distinguished Registered...

at 16:15
UpHealth, Inc. ("UpHealth," the "Company") , a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced...

at 16:15
Rodan + Fields ("R+F" or "the Company")?a brand known for delivering proven results in skincare and haircare through science-backed, dermatologist-created products?today announced a simplified business model to unlock growth and reach new...

at 16:10
Envista Holdings Corporation today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial...

at 16:05
Tilray Brands, Inc. ("Tilray" or the "Company") , a leading global lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its fourth quarter and full fiscal year ended May 31, 2024 on July...

News published on and distributed by: